0001209191-24-003198.txt : 20240213 0001209191-24-003198.hdr.sgml : 20240213 20240213172141 ACCESSION NUMBER: 0001209191-24-003198 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240210 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Justin CENTRAL INDEX KEY: 0001812025 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 24630092 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION STREET 2: 2100 POWELL STREET, SUITE 1900 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-10 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001812025 Burgess Justin C/O DYNAVAX TECHNOLOGIES 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 0 1 0 0 Chief Accounting Officer 0 Common Stock 2024-02-10 4 M 0 6667 A 11635 D Common Stock 2024-02-12 4 F 0 2499 12.82 D 9136 D Restricted Stock Unit 2024-02-10 4 M 0 6667 D Common Stock 6667 6666 D Code M: Exercise or conversion of derivative security Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022. Code F: Payment of exercise price or tax liability by delivering or withholding securities Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units. /s/ JUSTIN BURGESS 2024-02-13